Tel:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@anticorps-enligne.fr

Recombinant BCL6 anticorps (AA 256-389)

Cet anticorps Souris Monoclonal détecte spécifiquement BCL6 dans WB. Il présente une réactivité envers Humain.
N° du produit ABIN6936497

Aperçu rapide pour Recombinant BCL6 anticorps (AA 256-389) (ABIN6936497)

Antigène

Voir toutes BCL6 Anticorps
BCL6 (B-Cell CLL/lymphoma 6 (BCL6))

Type d'anticorp

Recombinant Antibody

Reactivité

  • 157
  • 59
  • 23
  • 9
  • 3
  • 2
  • 1
  • 1
  • 1
  • 1
  • 1
Humain

Hôte

  • 90
  • 65
  • 2
  • 1
Souris

Clonalité

  • 98
  • 60
Monoclonal

Conjugué

  • 77
  • 13
  • 7
  • 6
  • 6
  • 6
  • 6
  • 6
  • 6
  • 4
  • 3
  • 3
  • 3
  • 3
  • 3
  • 3
  • 2
  • 1
Cet anticorp BCL6 est non-conjugé

Application

  • 69
  • 68
  • 40
  • 36
  • 32
  • 26
  • 18
  • 11
  • 11
  • 8
  • 5
  • 2
  • 2
  • 2
  • 1
  • 1
  • 1
  • 1
  • 1
Western Blotting (WB)

Clone

RBCL6-1475
  • Épitope

    • 60
    • 11
    • 11
    • 7
    • 4
    • 4
    • 3
    • 3
    • 3
    • 3
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    AA 256-389

    Specificité

    The specificity of this monoclonal antibody to its intended target was validated by HuProtTM Array, containing more than 19,000, full-length human proteins. Recognizes a protein of 95kDa, which is identified as Bcl-6. Antibody to bcl-6 is helpful in a number of diagnostic settings: (1) In the differential diagnosis of small B-cell lymphoma. Follicular lymphoma will show bcl-6 (and CD10) positivity whereas other small B-cell lymphomas are usually negative. (2) Bcl-6 is an important prognostic marker in diffuse large B-cell lymphomas (DLBCL), where CD10, bcl-6 and MUM1/IRF4 are used to identify germinal center and activated B-cell phenotypes. (3) Bcl-6 can be valuable in distinguishing classical Hodgkin lymphoma from nodular lymphocyte predominant Hodgkin lymphoma (NLPHL). The Reed-Sternberg cells of classical Hodgkin lymphoma are bcl-6 negative whereas the large ('LH') cells of NLPHL are bcl-6 positive. In contrast, anti-Bcl-6 rarely stains mantle-cell lymphoma and MALT lymphoma.

    Réactivité croisée (Details)

    Human.

    Purification

    1.0mg/ml of Ab purified from Bioreactor by Protein A/G.

    Immunogène

    Recombinant human bcl-6 protein fragment (around aa256-389) (exact sequence is proprietary)

    Isotype

    IgG1 kappa
  • Indications d'application

    Known_Application: Western Blot (1-2 μg/mL), Optimal dilution for a specific application should be determined.

    Positive_Control: Raji or Ramos cells. Tonsil.

    Restrictions

    For Research Use only
  • Concentration

    1.0 mg/mL

    Buffer

    Prepared in 10 mM PBS, WITHOUT BSA and Azide.

    Agent conservateur

    Azide free

    Stock

    -20 °C,-80 °C

    Stockage commentaire

    Antibody without azide store at -20 to -80 °C. Antibody is stable for 24 months. Non-hazardous.

    Date de péremption

    24 months
  • Antigène

    BCL6 (B-Cell CLL/lymphoma 6 (BCL6))

    Autre désignation

    BCL6

    Sujet

    B-cell lymphoma 5 protein (BCL5), B-Cell Lymphoma 6 Protein, BCL6A, cys his2 zinc finger transcription factor, Lymphoma Associated Zinc Finger Gene On Chromosome 3 (LAZ3), Zinc finger and BTB domain-containing protein 27 (ZBTB27), Zinc Finger Protein 51 (ZNF51), zinc finger transcription factor BCL6S,Bcl-6 (Follicular Lymphoma Marker)
    Cellular localisation: Nuclear

    Poids moléculaire

    95kDa

    ID gène

    604, 478588

    UniProt

    P41182

    Pathways

    Chromatin Binding, Regulation of Leukocyte Mediated Immunity, Production of Molecular Mediator of Immune Response, Protein targeting to Nucleus
Vous êtes ici:
Chat with us!